Ryan Lakin, Abbott DVP of R&D, discusses opportunities in neuromodulation in an interview with Smart...
Dr. Marc Russo discusses dorsal horn dendrite stimulation, a new paradigm for SCS, and making it availab...
In the market for neuromodulation, companies are developing spinal cord stimulation (SCS), deep brain st...
Wallaby Medical announced it has acquired phenox GmbH, including phenox's femtos GmbH, a German-based ne...
Abbott’s Binith Cheeran, MD, PhD discusses the latest trends in DBS as well as the Company’s strategies ...
Spinal Cord Stimulation companies had a strong start in Q421 but the market lost steam as the Omicron va...
Abbott’s Allen Burton, MD discusses the Company’s new MRI labeling, expanded payer coverage for DRG, big...
Medtronic Neuromodulation executives Dave Anderson and Charlie Covert discuss the Company and the future...
D. Keith Grossman, chairman, CEO and president of Nevro Corporation, discusses the Company, expanding in...
A big boost in Q2 with double-digit gains in all segments. The US and WW SCS Market boomeranged to pre-C...
Login